Lower gastrointestinal tract bleeding caused by Klipple-Trenaunay syndrome and intestinal vascular malformation:a case report

肠道血管畸形引起下消化道出血较为少见,但在下消化道不明原因出血中占有重要地位,本病例肠道血管畸形合并klIPPEl-TrEnAunAy综合征(klIPPlE-TrEnAunAy SyndrOME,kTS).针对本病例,应首要解决脉管畸形所致的肠道出血,再联合其他学科进行综合治疗.Lower gastrointestinal bleeding caused by vascular malformation is rare but occupies an important position in lower gastrointestinal bleeding of unknown causes.Here we report a case of lower gastrointestinal bleeding caused by intestinal vascular malformation and Klippel-Trenaunay syndrome.For this case,intestinal bleeding caused by vascular malformation was treated firstly,and comprehensive treatment followed

三苯氧胺抗胆管癌机制的研究进展

胆管癌(cholangiocarcinoma,CCA)是一种来源于肝内或肝外胆管上皮细胞的恶性肿瘤.早期诊断困难,临床疗效差和5年生存率低等特点使之成为临床重点攻坚肿瘤.因此,需要研究和开发新型有效的化疗药物.三苯氧胺(tamoxifen,TAM)是一种非甾体类抗雌激素药物,临床上主要用于乳腺癌的治疗,对其他肿瘤包括CCA也有抑制活性,但具体机制尚不完全清楚.本文主要阐述TAM抗CCA机制的研究进展

Application of the three-dimensional visualization and 3D printing technology for the preoperative evaluation of retroperitoneal tumors

目的探讨三维重建及3D打印技术在腹膜后肿瘤术前评估中的应用价值。方法回顾性分析2011年3月至2015年9月厦门大学附属成功医院收治的50例腹膜; 后肿瘤病人的临床资料,应用人体器官三维建模软件将病人的CT二维图像重建成三维可视化图像,使用人体器官模型3D打印设备,用两色热塑性塑料打印实物模; 型,通过观察肿瘤与腹腔器官、腹部大血管之间的关系进行术前评估并制定手术方案。实施手术,术中比较重建结果与实际的区别。结果50例病人均成功完成三维; 重建,其中10例病人完成3D打印,三维重建结果及3D打印模型能够立体、清晰和实物化的显示肿瘤解剖学位置及与周围器官、血管的毗邻关系,与术中实际情; 况大致相符。50例病人均顺利施行手术,术中无死亡。结论三维重建及3D打印技术能够对腹膜后肿瘤术前进行精准评估,对指导手术具有一定的应用价值。Objective To explore the application value of three dimensional; visualization and 3D printing technology in the preoperative evaluation; of retroperitoneal tumors. Methods March 2011 to September 2015,the; clinical data of 50 cases of retroperitoneal tumor patients in Xiamen; University Affiliated successful hospital were retrospectively analyzed.; Xiamen strong science and technology R & D human organ 3D modeling; software will reconstruct 2D CT image visualization into a; three-dimensional visualization image,and then it can print physical; model with the company's XMQB-I human organ model 3D printing equipment; and white thermoplastic. At last,preoperative evaluation and surgical; plan can be made through the relationship between the tumor,organs in; abdominal cavity,and abdominal vascular. During the surgery,make a; comparison between the visualization results with the actual condition.; Results 50 cases of patients were successfully completed the; three-dimensional visualization,including 10 cases of patients; completed. Three-dimensional visualization and 3D printing model can; three-dimensionally,clearly show the adjacent relationship between the; anatomical tumour location and surrounding organs and blood; vessels,broadly in line with the actual surgery. 50 surgeries were; successfully performed,no death during perioperative period. Conclusion; Three dimensional visualization and 3D printing technology can make an; accurate preoperative evaluation of retroperitoneal tumors,which has a; certain application value for guiding surgery.国家自然科学基

河蚬乙酸乙酯提取物的抗氧化活性及其对人胆管癌细胞的抑制作用

作为传统中药的河蚬具有退热、治疗肝病和解酒等功效.以新鲜河蚬(Corbicula fluminea)肉为原料,经甲醇抽提,乙酸乙酯萃取等方法得到河蚬乙酸乙酯提取物.运用DPPH法检测其清除自由基的能力,通过MTT法和倒置显微镜观察其对人胆管癌细胞QBC939生长的影响,并通过流式细胞术分析其对QBC939细胞周期的影响.结果显示:河蚬乙酸乙酯提取物对DPPH自由基具有一定的清除作用,在较低的浓度下有较高的清除效果,IC50值为0.6 mg/mL,且随其浓度的增加而不断增强;河蚬乙酸乙酯提取物对QBC939细胞有显著的抑制作用,处理48 h,IC50值为250μg/mL,细胞形态发生明显变化;处理后的QBC939细胞出现明显的凋亡峰.研究表明:河蚬乙酸乙酯提取物不但具有抗氧化活性,且对体外培养的QBC939细胞具有明显的增殖抑制作用,能够改变QBC939细胞周期分布,并诱导QBC939细胞发生凋亡.说明河蚬乙酸乙酯提取物可能具有天然药物开发的潜力,同时也为胆管癌的防治提供新的思路和方法

河蚬提取物对人肝癌细胞SMMC-7721的抑制作用

以河蚬(Corbicula fluminea)为材料,经过甲醇抽提,乙酸乙酯萃取等方法得到河蚬提取物(CFE).用MTT法检测其对肝癌细胞株的抑制作用,借助光学倒置显微镜以及流式细胞术考察CFE对细胞的形态及细胞周期的影响.实验结果表明:CFE对肝癌细胞SMMC-7721有增殖抑制作用,处理72 h细胞形态发生了明显变化,其IC50值为70μg/mL.FMC的结果显示,经CFE处理后的肝癌SMMC-7721细胞出现明显的凋亡峰.这说明CFE有效抑制了体外培养的肝癌细胞增殖,并且能够改变癌细胞的形态及细胞周期的分布,诱导癌细胞出现凋亡

结肠癌伴孤立巨大肝转移切除术一例

患者男,72岁,因“反复中上腹胀痛不适1月余“入院;既往有乙肝病史,无高血压、糖尿病、心脏病等病史,无手术史。入院查CT示:左肝巨大占位,约22.1 CMx11.3 CM,与胃小弯粘连(图1);门静脉右支无显示(图2),左结肠壁增厚,考虑结肠癌肝转移可能。肿瘤标记物检查示:CEA 54.52μg/l,CA19-9 120.10 u/Ml,AfP正常,血常规、血液生化分析未见国家自然科学基金资助项目(81272246、81101502、61271336、61327001

Effect of sorafenib and celecoxib combination therapy on proliferation of the human cholangiocarcinoma cell line SK-ChA-1 in vitro

目的研究索拉非尼联合塞来昔布在体外对胆管癌细胞株Sk-CHA-1增殖的影响。方法体外培养人胆管癌细胞株Sk-CHA-1,通过MTT法检测索拉非尼单用或与塞来昔布联用时对胆管癌细胞株增殖的抑制作用,WESTErn blOT分析索拉非尼单用或与塞来昔布联用时对胆管癌细胞株内多聚AdP核糖聚合酶(PArP)蛋白表达的影响。结果索拉非尼抑制胆管癌细胞株Sk-CHA-1的增殖并诱导细胞凋亡。索拉非尼联合塞来昔布协同抑制胆管癌细胞株Sk-CHA-1的增殖。塞来昔布使索拉非尼诱导的胆管癌细胞株Sk-CHA-1的凋亡增加。结论索拉非尼联合塞来昔布能协同抑制胆管癌细胞株Sk-CHA-1的增殖,这与塞来昔布使索拉非尼诱导的细胞凋亡增加有关。Objective To investigate the effect of sorafenib and celecoxib combination therapy on proliferation of human cholangiocarcinoma(CC) cells,using the cultured SK-ChA-1 cell line.Methods Inhibition of SK-ChA-1 cell proliferation by sorafenib alone and in combination with celecoxib was studied in vitro using the MTT assay.The anti-neoplastic mechanisms of sorafenib alone and in combination with celecoxib were assessed by Western blot detection of changes in the caspase cleavage substrate poly ADP-ribose polymerase(PARP).Results SK-ChA-1 cells treated with sorafenib alone showed a dose-dependent growth inhibition and degradation of PARP.Combination treatment with sorafenib and celecoxib synergistically increased the growth inhibition effects and enhanced the degradation of PARP.Conclusion Combination treatment with sorafenib and celecoxib results in a synergistic anti-proliferative effect in the human CC cell line SK-ChA-1;the addition of celecoxib enhances sorafenib-induced apoptosis.国家自然科学基金资助项目(81072014

胆管癌患者与健康志愿者血清样品蛋白质表达差异分析

胆管癌(cholangiocarcinoma,CCA)是一种难于早期诊断和治疗的恶性肿瘤.利用蛋白质组学技术以期筛选出人血清中具有医学价值的胆管癌癌变的标志物.利用白蛋白/IgG去除试剂盒去除血清中高丰度的白蛋白和IgG,再经丙酮沉淀得到高质量的血清样品.样品经双向电泳(2-DE)得到了分辨率较好的胆管癌血清的蛋白点图谱.利用ImageMaster2D软件对比分析了胆管癌病人和正常健康对照组的2-DE图谱.其中,表达上调蛋白有8个,表达下调蛋白有6个.用质谱获得上述差异蛋白的肽质量指纹图谱,并经数据库检索共鉴定出了11种差异蛋白质,其中8种蛋白质的表达与胆管癌密切相关.本研究为阐明胆管癌的机理提供了一条新途径

文蛤多肽的体外抗癌活性研究

采用硫酸铵沉淀、有机溶剂分离、Sephadex G-25分子筛层析等实验方法,从文蛤肉中提取了一种低分子量的多肽,命名为Mer2.本文以溴化二苯偶氮盐(MTT)法检测Mer2对体外培养的癌细胞的抑制作用.结果表明Mer2对体外培养的人肝癌细胞株(HepG2)、宫颈癌细胞株(Hela)、胆管癌细胞株(QBC939)、肺癌细胞株(SPC-A-1和LTEP-a-2)的生长均有很强的抑制作用,且抑制效果随着Mer2含量的增高和处理时间的延长而增强,证明Mer2具有广谱的抗癌活性.其中Mer2对人肝癌HepG2细胞株抑制作用最为显著,光学显微镜观察经Mer2细胞培养液处理后的细胞形态发生明显的改变,流式细胞仪实验的结果表明处理后的细胞周期发生明显的改变,并在G0/G1期前出现凋亡峰

胆管癌血清双向凝胶电泳技术的优化

本研究为筛选胆管癌癌变的标志物,开发相应的药物研究,通过对胆管癌血清双向电泳的样品处理、pH范围、上样量的选择、电泳参数的设置和SDS凝胶电泳染色方法等进行比较优化.确定了样品预处理后通过Millpore公司推出的Montage Albumin Deplete kit去除血清中高丰度的白蛋白,再经丙酮沉淀,用裂解液溶解后,采用pH3.5~10与pH5~8的两性载体电解质以体积比1∶4混合使用,100μg的上样量,12.5%的SDS-PAGE胶,16 mA/胶进行双向电泳的电泳体系.优化了胆管癌血清双向凝胶电泳的条件,得到了分辨率较好的胆管癌血清的蛋白图谱,为进一步的研究奠定了基础